Skip to main content
. 2019 Jul 8;51(7):76. doi: 10.1038/s12276-019-0274-7

Table 1.

Half-maximal inhibitory concentration (IC50) of apatinib and sorafenib in hepatocellular carcinoma cell lines

Cell line IC50 of apatinib (μM) IC50 of sorafenib (μM)
HUH7 23.35 5.95
HepG2 49.66 32.25
Hep3B 25.83 8.30
SMMC-7721 28.72 20.08
BEL-7402 54.22 29.17